Varespladib

N/A

Report date: 2023/02/10 15:27:17
NME

Base Information

Drug NameVarespladib
Drug Alias Namevarespladibum伐瑞拉地伐瑞拉迪A-001S-5920 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSecretory phospholipase A2 inhibitors
TargetsSecretory phospholipase A2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Anemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co LtdEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnthera Pharmaceuticals IncOphirex Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Anemia, Sickle Cell

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG